Status:
COMPLETED
Optimized 2D-RT for Prostate Cancer
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions:
Prostate Cancer
Eligibility:
MALE
18-79 years
Phase:
NA
Brief Summary
Prostate cancer (CAP) is one of the most common malignancies in men, both in Western countries and developing countries. Radiation therapy (RT) is an important therapeutic option. New technologies (3D...
Eligibility Criteria
Inclusion
- \> 18 years
- clinical T stage: cT2b, cT2c, cT3a, cT3b
- informed consent
- MRI of the pelvis
Exclusion
- \> 79 years
- prior surgery treatment for prostate cancer
- prior pelvic radiotherapy
- genetic syndromes of hyper-radio-sensitivity
- chronic infiammatory bowel disease
Key Trial Info
Start Date :
February 2 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2015
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03339531
Start Date
February 2 2015
End Date
December 18 2015
Last Update
March 13 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.